Volume 117, Issue 2, Pages (August 1999)

Slides:



Advertisements
Similar presentations
Volume 124, Issue 7, Pages (June 2003)
Advertisements

Volume 132, Issue 1, Pages (January 2007)
Volume 124, Issue 5, Pages (May 2003)
Hon-Wai Koon, Dezheng Zhao, Hua Xu, Collin Bowe, Alan Moss, Mary P
Volume 114, Issue 4, Pages (April 1998)
Volume 136, Issue 2, Pages e5 (February 2009)
Volume 128, Issue 4, Pages (April 2005)
Volume 123, Issue 4, Pages (October 2002)
Serotonin Has a Key Role in Pathogenesis of Experimental Colitis
Daniel K. Podolsky, Guido Gerken, Annette Eyking, Elke Cario 
Domain-dependent action of urokinase on smooth muscle cell responses
Volume 124, Issue 5, Pages (May 2003)
Volume 136, Issue 3, Pages (March 2009)
Volume 130, Issue 2, Pages (February 2006)
Volume 131, Issue 4, Pages (October 2006)
Volume 123, Issue 4, Pages (October 2002)
Volume 132, Issue 1, Pages (January 2007)
Therapeutic potential of follistatin for colonic inflammation in mice
Volume 125, Issue 6, Pages (December 2003)
Volume 119, Issue 2, Pages (August 2000)
Volume 124, Issue 5, Pages (May 2003)
Volume 127, Issue 2, Pages (August 2004)
Volume 131, Issue 3, Pages (September 2006)
Volume 114, Issue 4, Pages (April 1998)
Galectin-1 suppresses experimental colitis in mice
Volume 120, Issue 2, Pages (February 2001)
Volume 122, Issue 5, Pages (May 2002)
Volume 141, Issue 3, Pages (September 2011)
Volume 124, Issue 3, Pages (March 2003)
Volume 63, Issue 2, Pages (February 2003)
Volume 140, Issue 7, Pages (June 2011)
Hyaluronan and proximal tubular cell migration
Volume 115, Issue 2, Pages (August 1998)
Volume 134, Issue 1, Pages (January 2008)
Volume 123, Issue 1, Pages (July 2002)
Volume 57, Issue 3, Pages (March 2000)
Volume 117, Issue 3, Pages (September 1999)
Volume 138, Issue 2, Pages (February 2010)
Volume 118, Issue 6, Pages (June 2000)
Volume 125, Issue 6, Pages (December 2003)
Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: Role of PI 3-kinase and ERK  Richard J. Dixon, Nigel J. Brunskill 
Uptake and presentation of antigen to T cells by primary colonic epithelial cells in normal and diseased states  Grzegorz W. Telega, *,‡, Daniel C. Baumgart,
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 125, Issue 1, Pages (July 2003)
Volume 116, Issue 4, Pages (April 1999)
Volume 119, Issue 4, Pages (October 2000)
Volume 135, Issue 5, Pages e5 (November 2008)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 120, Issue 2, Pages (February 2001)
Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis  Basilia Zingarelli,
Izabella Z.A. Pawluczyk, Kevin P.G. Harris  Kidney International 
Leptin: A pivotal mediator of intestinal inflammation in mice
Volume 120, Issue 2, Pages (February 2001)
Volume 119, Issue 3, Pages (September 2000)
Helminth Infection Enhances Disease in a Murine TH2 Model of Colitis
Volume 123, Issue 1, Pages (July 2002)
Volume 125, Issue 4, Pages (October 2003)
Volume 132, Issue 2, Pages (February 2007)
Autocrine Regulation of Re-Epithelialization After Wounding by Chemokine Receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3  Kim L. Kroeze, Mireille A. Boink,
Volume 121, Issue 4, Pages (October 2001)
Ganglioside GQ1b enhances Ig production by human PBMCs
Volume 122, Issue 1, Pages (January 2002)
Volume 117, Issue 5, Pages (November 1999)
T. Shibahara, J.N. Wilcox, T. Couse, J.L. Madara  Gastroenterology 
TAK1 Is Required for Dermal Wound Healing and Homeostasis
Volume 125, Issue 3, Pages (September 2003)
Volume 136, Issue 7, Pages (June 2009)
Harald Renz, MD, Chaya Brodie, PhD, Katherine Bradley, BS, Donald Y. M
Differential effects of simvastatin on mesangial cells
Presentation transcript:

Volume 117, Issue 2, Pages 368-377 (August 1999) Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid  Andreas Sturm, Thomas Sudermann, Klaus–Martin Schulte, Harald Goebell, Axel U. Dignass  Gastroenterology  Volume 117, Issue 2, Pages 368-377 (August 1999) DOI: 10.1053/gast.1999.0029900368

1 Fig. 1. Intestinal epithelial cell migration (restitution) in an in vitro model of epithelial restitution. Standard wounds were made with razor blades in confluent monolayers of IEC-6 cells as described in Materials and Methods. Wounded monolayers were cultured for 24 hours in (A) control medium or (B) medium supplemented with 50 μmol/L LPA. Scratch indicates the original margin of the wound (original magnification 200×). Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

1 Fig. 1. Intestinal epithelial cell migration (restitution) in an in vitro model of epithelial restitution. Standard wounds were made with razor blades in confluent monolayers of IEC-6 cells as described in Materials and Methods. Wounded monolayers were cultured for 24 hours in (A) control medium or (B) medium supplemented with 50 μmol/L LPA. Scratch indicates the original margin of the wound (original magnification 200×). Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

2 Fig. 2. Effect of LPA on intestinal epithelial cell restitution in vitro. Standard wounds were made with razor blades in confluent IEC-6 cell monolayers as described in Materials and Methods. Wounded monolayers were cultured for 24 hours in control medium or medium supplemented with 1-100 μmol/L LPA. Migration of IEC-6 cells was quantitated as described in Materials and Methods. Data represent means ± SD of at least 3 different experiments. +P < 0.05 vs. 0 μmol/L LPA (control); *P < 0.01 vs. 0 μmol/L LPA (control). Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

lished Fig. 3. Effects of bradykinin (BK; 1 μmol/L), phorbol ester (PE; 1 μmol/L), pertussis toxin (PTX; 50 ng/mL), suramin (SU; 0.5 mg/L), or anti–TGF-β (a-TGFβ; 30 μg/mL) on LPA-induced enhancement of intestinal epithelial cell migration in vitro. Standard wounds were established in confluent monolayers of IEC-6 cells as detailed in Materials and Methods, and wounded monolayers were cultured for 24 hours after addition of culture medium (DMEM with 5% FCS) with or without test substances. Cell migration (restitution) was quantitated as described in Materials and Methods. Data represent means ± SD of at least 3 different experiments. +P < 0.05 vs. 0 μmol/L LPA (control); *P < 0.01 vs. 0 μmol/L LPA (control). The phospholipid derivative phosphatidic acid (PA; 50 μmol/L), which was evaluated for control purposes, did not significantly modulate epithelial restitution. Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

4 Fig. 4. Effect of LPA on TGF-β peptide levels in supernatants of IEC-6 monolayers treated with LPA or control medium alone. TGF-β peptide levels were measured in the supernatants of IEC-6 monolayers treated with LPA or control medium alone as described in Materials and Methods. Supernatants were obtained after a 24-hour incubation period from both migration and proliferation studies. Data represent means ± SD of latent (■) and bioactive (2) TGF-β peptide levels obtained from 3 different experiments. Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

5 Fig. 5. Effect of LPA on the proliferation of intestinal cell epithelial cells (IEC-6) in vitro. IEC-6 cells were cultured in the presence of 0-100 μmol/L LPA, and cell proliferation was assessed by colorimetric MTT assays as described in Materials and Methods. ■, 5% FCS; 2, 0.1% FCS. Data represent means ± SD of absorbance values obtained for a typical experiment performed with quadruplicate assays. Comparable data were obtained in four independently performed experiments. *P < 0.01 vs. 0 μmol/L LPA (control). Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

6 Fig. 6. Effects of bradykinin (BK), phorbol ester (PE), pertussis toxin (PTX), suramin (SU), or anti–TGF-β (a-TGFβ) on LPA-induced inhibition of intestinal epithelial cell proliferation in vitro. IEC-6 cells (n = 2 × 104) were seeded into 24-well plates in DMEM containing 5% FCS. Simultaneously, LPA (50 μmol/L), bradykinin (1 μmol/L), phorbol ester (1 μmol/L), pertussis toxin (50 ng/mL), suramin (0.5 mg/mL), or a panspecific TGF-β antibody (30 μg/mL) were added to individual wells. After an incubation period of 72 hours, cell proliferation was assessed by colorimetric MTT assays as described in Materials and Methods. Data represent means ± SD of absorbance values obtained for a typical experiment performed with quadruplicate assays. Comparable data were obtained in at least 3 independently performed experiments. +P < 0.01 vs. 0 μmol/L LPA (control); *P < 0.01 vs. 50 μmol/L LPA. The phospholipid derivative phosphatidic acid (PA; 50 μmol/L), which was evaluated for control purposes, did not significantly modulate epithelial proliferation. Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

7 Fig. 7. Effects of topical LPA treatment on weight loss and macroscopic mucosal damage in experimentally induced colitis in rats. Colitis was induced by intracolonic administration of 2,4,6-trinitrobenzene sulfonic acid as described in Materials and Methods. Rats were subsequently treated with rectal application of PBS (■; 18 animals) or LPA (▩; 18 animals), and weight loss and mucosal damage were assessed after 3 days of treatment as described in Materials and Methods. Data represent means ± SD. *P < 0.01 vs. control; **P < 0.005 vs. control. Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

8 Fig. 8. Effects of topical LPA treatment on mucosal damage in experimentally induced colitis in rats. Colitis was induced by intracolonic administration of 2,4,6-trinitrobenzene sulfonic acid as described in Materials and Methods. Rats were subsequently treated with rectal application of PBS or LPA. After 3 days of treatment, rats were killed and tissue samples were obtained from the distal 10 cm of the colon and prepared for histological evaluation as described in Materials and Methods. (A, C, and E) Sections of distal colon treated with PBS as control (H&E). (B, D, and F) Sections of distal colon treated with LPA (H&E; original magnifications: A, B, 80×; C, D, 120×; E, F, 200×). Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

8 Fig. 8. Effects of topical LPA treatment on mucosal damage in experimentally induced colitis in rats. Colitis was induced by intracolonic administration of 2,4,6-trinitrobenzene sulfonic acid as described in Materials and Methods. Rats were subsequently treated with rectal application of PBS or LPA. After 3 days of treatment, rats were killed and tissue samples were obtained from the distal 10 cm of the colon and prepared for histological evaluation as described in Materials and Methods. (A, C, and E) Sections of distal colon treated with PBS as control (H&E). (B, D, and F) Sections of distal colon treated with LPA (H&E; original magnifications: A, B, 80×; C, D, 120×; E, F, 200×). Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

8 Fig. 8. Effects of topical LPA treatment on mucosal damage in experimentally induced colitis in rats. Colitis was induced by intracolonic administration of 2,4,6-trinitrobenzene sulfonic acid as described in Materials and Methods. Rats were subsequently treated with rectal application of PBS or LPA. After 3 days of treatment, rats were killed and tissue samples were obtained from the distal 10 cm of the colon and prepared for histological evaluation as described in Materials and Methods. (A, C, and E) Sections of distal colon treated with PBS as control (H&E). (B, D, and F) Sections of distal colon treated with LPA (H&E; original magnifications: A, B, 80×; C, D, 120×; E, F, 200×). Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

8 Fig. 8. Effects of topical LPA treatment on mucosal damage in experimentally induced colitis in rats. Colitis was induced by intracolonic administration of 2,4,6-trinitrobenzene sulfonic acid as described in Materials and Methods. Rats were subsequently treated with rectal application of PBS or LPA. After 3 days of treatment, rats were killed and tissue samples were obtained from the distal 10 cm of the colon and prepared for histological evaluation as described in Materials and Methods. (A, C, and E) Sections of distal colon treated with PBS as control (H&E). (B, D, and F) Sections of distal colon treated with LPA (H&E; original magnifications: A, B, 80×; C, D, 120×; E, F, 200×). Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

8 Fig. 8. Effects of topical LPA treatment on mucosal damage in experimentally induced colitis in rats. Colitis was induced by intracolonic administration of 2,4,6-trinitrobenzene sulfonic acid as described in Materials and Methods. Rats were subsequently treated with rectal application of PBS or LPA. After 3 days of treatment, rats were killed and tissue samples were obtained from the distal 10 cm of the colon and prepared for histological evaluation as described in Materials and Methods. (A, C, and E) Sections of distal colon treated with PBS as control (H&E). (B, D, and F) Sections of distal colon treated with LPA (H&E; original magnifications: A, B, 80×; C, D, 120×; E, F, 200×). Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)

8 Fig. 8. Effects of topical LPA treatment on mucosal damage in experimentally induced colitis in rats. Colitis was induced by intracolonic administration of 2,4,6-trinitrobenzene sulfonic acid as described in Materials and Methods. Rats were subsequently treated with rectal application of PBS or LPA. After 3 days of treatment, rats were killed and tissue samples were obtained from the distal 10 cm of the colon and prepared for histological evaluation as described in Materials and Methods. (A, C, and E) Sections of distal colon treated with PBS as control (H&E). (B, D, and F) Sections of distal colon treated with LPA (H&E; original magnifications: A, B, 80×; C, D, 120×; E, F, 200×). Gastroenterology 1999 117, 368-377DOI: (10.1053/gast.1999.0029900368)